Heart failure & cardiomyopathies

Impact of Cannabidiol on Myocardial Recovery in Patients with Acute Myocarditis: Rationale & Design of the ARCHER Trial

ESC Heart FailPublished Rationale and design of a randomised controlled trial

Authors' conclusion

The ongoing ARCHER Trial is an international, multicentre, double-blind, randomized, placebo-controlled phase II study, designed to determine the effect of a pharmaceutically produced cannabidiol formulation on CMR parameters in patients presenting with acute myocarditis.

Study context

Population
Patients with mild to moderate acute myocarditis, randomised within 10 days of diagnostic cardiac MRI (CMR)planned
Participants
100 patients
Comparison
Cannabidiol vs placebo
Primary endpoint
Change in global longitudinal strain (GLS) and extracellular volume (extra cellular volume (ECV)) by CMR
Follow-up
12 weeks
Methodological detailsARCHER, international, multicentre, double-blind, placebo-controlled, phase II, Secondary endpoint: change in left ventricular ejection fraction (LVEF) from baseline to week 12, Enrolment expected to conclude Q3 2024; results early 2025, Sample size: 80% power, 5% alpha, 25% missing CMR data at week 12, treatment effect 18%, Exploratory: hs-troponin, NT-proBNP, inflammation and endothelial function markers
  • ARCHER
  • International
  • Multicentre
  • Double-blind
  • Placebo-controlled
  • Phase II
  • Secondary endpoint: change in LVEF from baseline to week 12
  • Enrolment expected to conclude Q3 2024; results early 2025
  • Sample size: 80% power, 5% alpha, 25% missing CMR data at week 12, treatment effect 18%
  • Exploratory: hs-troponin, NT-proBNP, inflammation and endothelial function markers

Primary result

As reported in the abstract

  • No interim data available; trial ongoing

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Impact of Cannabidiol on Myocardial Recovery in Patients with Acute Myocarditis: Rationale & Design of the ARCHER Trial. ESC Heart Fail. Published 27 June 2024. doi:10.1002/ehf2.14889

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.